Invention Grant
- Patent Title: Use of 20-hydroxyecdysone and the derivatives thereof in the treatment of myopathies
-
Application No.: US16609205Application Date: 2018-04-27
-
Publication No.: US11542295B2Publication Date: 2023-01-03
- Inventor: Pierre Dilda , René Lafont , Mathilde Latil , Maria Serova , Onnik Agbulut , Stanislas Veillet
- Applicant: BIOPHYTIS , SORBONNE UNIVERSITE
- Applicant Address: FR Paris; FR Paris
- Assignee: BIOPHYTIS,SORBONNE UNIVERSITE
- Current Assignee: BIOPHYTIS,SORBONNE UNIVERSITE
- Current Assignee Address: FR Paris; FR Paris
- Agency: Ladas & Parry LLP
- Agent Malcolm J. MacDonald
- Priority: FR1753775 20170428,FR1758071 20170831
- International Application: PCT/EP2018/060975 WO 20180427
- International Announcement: WO2018/197708 WO 20181101
- Main IPC: C07J9/00
- IPC: C07J9/00 ; A61P21/06 ; A61K31/575
Abstract:
The invention relates to 20-hydroxyecdysone and the derivatives thereof, for use in the treatment of genetic myopathies.
Public/Granted literature
- US20200179407A1 USE OF 20-HYDROXYECDYSONE AND THE DERIVATIVES THEREOF IN THE TREATMENT OF MYOPATHIES Public/Granted day:2020-06-11
Information query
